» Articles » PMID: 34667751

Acquired Dermal Macular Hyperpigmentation: An Update

Overview
Specialty Dermatology
Date 2021 Oct 20
PMID 34667751
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Acquired dermal macular hyperpigmentation (ADMH) is an umbrella term that includes disorders clinically characterized by small and large pigmented macules/patches and histopathologically showing an evidence of current or resolved interface dermatitis with pigment incontinence, without clinically significant prior inflammatory phase. The term intends to include diseases previously described in the literature as lichen planus pigmentosus, Riehl's melanosis/pigmented cosmetic dermatitis and ashy dermatosis/erythema dyschromicum perstans. The nomenclature and origin of these disorders have always been a matter of discussion. These disorders share many clinicopathological similarities, are difficult to treat and adversely affect the quality of life. Recent consensus points towards the need for a unifying term to facilitate research and therapeutic trials. This article aims to provide a comprehensive review of the recent advances in ADMH.

Citing Articles

Dickkopf 1 and Neuregulin 1 as cutaneous biomarkers for dermal pigmentation activity in acquired dermal macular hyperpigmentation (ADMH): a case control study.

Gupta A, Sharma A, Kumar V, Kaushal L, Vinay K, Kumaran M Arch Dermatol Res. 2025; 317(1):378.

PMID: 39921734 DOI: 10.1007/s00403-025-03906-8.


Lichen Planus Pigmentosus: A Clinicopathological Study From Northeast India.

Beso A, Chhangte M, Dey B, Verma S Cureus. 2024; 16(11):e74627.

PMID: 39735114 PMC: 11681959. DOI: 10.7759/cureus.74627.


Frontal Fibrosing Alopecia: An Update.

Messenger A, Asfour L, Harries M Am J Clin Dermatol. 2024; 26(2):155-174.

PMID: 39699852 DOI: 10.1007/s40257-024-00912-w.


A clinico-epidemiological study of different dermoscopic patterns in hyperpigmented facial lesions in a tertiary care centre.

Solanki V, Dongre A, Nayak C J Cutan Aesthet Surg. 2024; 17(2):112-123.

PMID: 38800811 PMC: 11126221. DOI: 10.4103/JCAS.JCAS_48_23.


Advancements in Laser Therapies for Dermal Hyperpigmentation in Skin of Color: A Comprehensive Literature Review and Experience of Sequential Laser Treatments in a Cohort of 122 Indian Patients.

Garg S, Vashisht K, Garg D, Oberoi B, Sharma G J Clin Med. 2024; 13(7).

PMID: 38610881 PMC: 11012689. DOI: 10.3390/jcm13072116.


References
1.
Kumaran M, Dabas G, Parsad D, Vinay K . Lichen planus pigmentosus - An appraisal. Int J Dermatol. 2018; 57(6):748-750. DOI: 10.1111/ijd.13982. View

2.
Rorsman H . Riehl's melanosis. Int J Dermatol. 1982; 21(2):75-8. DOI: 10.1111/j.1365-4362.1982.tb00500.x. View

3.
Xu Z, Xing X, Zhang C, Chen L, Xiang L . A pilot study of oral tranexamic acid and Glycyrrhizin compound in the treatment of recalcitrant Riehl's melanosis. J Cosmet Dermatol. 2018; 18(1):286-292. DOI: 10.1111/jocd.12797. View

4.
Pock L, Jelinkova L, Drlik L, Abrhamova S, Vojtechovska S, Sezemska D . Lichen planus pigmentosus-inversus. J Eur Acad Dermatol Venereol. 2002; 15(5):452-4. DOI: 10.1046/j.1468-3083.2001.00347.x. View

5.
Muthu S, Narang T, Saikia U, Kanwar A, Parsad D, Dogra S . Low-dose oral isotretinoin therapy in lichen planus pigmentosus: an open-label non-randomized prospective pilot study. Int J Dermatol. 2016; 55(9):1048-54. DOI: 10.1111/ijd.13293. View